Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

269 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validation of dilution of plasma samples with phosphate buffered saline to eliminate the problem of small volumes associated with children infected with HIV-1 for viral load testing using Cobas AmpliPrep/COBAS TaqMan HIV-1 test, version 2.0 (CAP CTM HIV v2.0).
Mine M, Nkoane T, Sebetso G, Sakyi B, Makhaola K, Gaolathe T. Mine M, et al. J Virol Methods. 2013 Dec;194(1-2):217-21. doi: 10.1016/j.jviromet.2013.08.031. Epub 2013 Sep 8. J Virol Methods. 2013. PMID: 24025342
Impact of human immunodeficiency virus type 1 subtype C on drug resistance mutations in patients from Botswana failing a nelfinavir-containing regimen.
Doualla-Bell F, Avalos A, Gaolathe T, Mine M, Gaseitsiwe S, Ndwapi N, Novitsky VA, Brenner B, Oliveira M, Moisi D, Moffat H, Thior I, Essex M, Wainberg MA. Doualla-Bell F, et al. Among authors: mine m. Antimicrob Agents Chemother. 2006 Jun;50(6):2210-3. doi: 10.1128/AAC.01447-05. Antimicrob Agents Chemother. 2006. PMID: 16723586 Free PMC article.
High prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimens.
Doualla-Bell F, Avalos A, Brenner B, Gaolathe T, Mine M, Gaseitsiwe S, Oliveira M, Moisi D, Ndwapi N, Moffat H, Essex M, Wainberg MA. Doualla-Bell F, et al. Among authors: mine m. Antimicrob Agents Chemother. 2006 Dec;50(12):4182-5. doi: 10.1128/AAC.00714-06. Epub 2006 Oct 2. Antimicrob Agents Chemother. 2006. PMID: 17015626 Free PMC article.
Early diagnosis of human immunodeficiency virus in infants using polymerase chain reaction on dried blood spots in Botswana's national program for prevention of mother-to-child transmission.
Creek T, Tanuri A, Smith M, Seipone K, Smit M, Legwaila K, Motswere C, Maruping M, Nkoane T, Ntumy R, Bile E, Mine M, Lu L, Tebele G, Mazhani L, Davis MK, Roels TH, Kilmarx PH, Shaffer N. Creek T, et al. Among authors: mine m. Pediatr Infect Dis J. 2008 Jan;27(1):22-6. doi: 10.1097/INF.0b013e3181469050. Pediatr Infect Dis J. 2008. PMID: 18162933
Response to zidovudine/didanosine-containing combination antiretroviral therapy among HIV-1 subtype C-infected adults in Botswana: two-year outcomes from a randomized clinical trial.
Bussmann H, Wester CW, Thomas A, Novitsky V, Okezie R, Muzenda T, Gaolathe T, Ndwapi N, Mawoko N, Widenfelt E, Moyo S, Musonda R, Mine M, Makhema J, Moffat H, Essex M, Degruttola V, Marlink RG. Bussmann H, et al. Among authors: mine m. J Acquir Immune Defic Syndr. 2009 May 1;51(1):37-46. doi: 10.1097/QAI.0b013e31819ff102. J Acquir Immune Defic Syndr. 2009. PMID: 19282782 Free PMC article. Clinical Trial.
Prevalence of transmitted HIV drug resistance in Botswana: lessons learned from the HIVDR-Threshold Survey conducted among women presenting for routine antenatal care as part of the 2007 national sentinel survey.
Bussmann H, de la Hoz Gomez F, Roels TH, Wester CW, Bodika SM, Moyo S, Taffa N, Anderson MG, Mine M, Bile EC, Yang C, Mphoyakgosi K, Lehotzky EA, Mlotshwa B, Mmelesi M, Seipone K, Makhema MJ, Marlink RG, Novitsky V, Essex M. Bussmann H, et al. Among authors: mine m. AIDS Res Hum Retroviruses. 2011 Apr;27(4):365-72. doi: 10.1089/aid.2009.0299. Epub 2010 Oct 29. AIDS Res Hum Retroviruses. 2011. PMID: 21034246
Validation of A Point-of-Care Lactate Device For Screening At-Risk Adults Receiving Combination Antiretroviral Therapy In Botswana.
Moyo S, Bussmann H, Mangwendeza P, Dusara P, Gaolathe T, Mine M, Musonda R, van Widenfelt E, Novitsky V, Makhema J, Marlink RG, Essex M, Wester CW. Moyo S, et al. Among authors: mine m. J Antivir Antiretrovir. 2011 Oct;3(4):45-48. doi: 10.4172/jaa.1000034. Epub 2011 Sep 20. J Antivir Antiretrovir. 2011. PMID: 23087782 Free PMC article.
Immunohaematological reference values for HIV-negative healthy adults in Botswana.
Mine M, Moyo S, Stevens P, Michael K, Novitsky V, Makhaola K, Asmelash A, Molefhabangwe S, Woldegabriel E, Mothowaeng G, Maruta T, Kamhukamwe C, Mangwendeza PM, Holmes-Pretorius M, Mtoni I, Motswaledi M, Musonda R, Ndwapi N, Makhema J, Marlink R, Seipone K, Gaolathe T, Essex M. Mine M, et al. Afr J Lab Med. 2012;1(1):5. doi: 10.4102/ajlm.v1i1.5. Afr J Lab Med. 2012. PMID: 23772402 Free PMC article.
269 results